Cadrenal Therapeutics, Inc. · NASDAQ:CVKD
Cadrenal Therapeutics, Inc. shareholders
As of Jun 30, 2026, 16 institutions reported holding Cadrenal Therapeutics, Inc., 3.2% of its shares. Largest: Vanguard, Hrt Financial LP and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cadrenal Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 58,448 | 1.6% | +4,936 | Aug 13, 2026 |
| Hrt Financial LP | 29,055 | 0.81% | new | Aug 14, 2026 |
| Geode Capital | 19,024 | 0.53% | −2,602 | Aug 12, 2026 |
| Tower Research Capital LLC (TRC) | 1,282 | 0.04% | +889 | Aug 11, 2026 |
| UBS | 1,112 | 0.03% | +1,109 | Aug 13, 2026 |
| Grove Bank & Trust | 1,000 | 0.03% | new | Jul 7, 2026 |
| Morgan Stanley | 706 | 0.02% | +606 | Aug 13, 2026 |
| Clearstead Advisors, LLC | 650 | 0.02% | new | Aug 6, 2026 |
| Quest 10 Wealth Builders, Inc. | 380 | 0.01% | new | Jul 24, 2026 |
| Osaic Holdings, Inc. | 300 | <0.01% | no change | Aug 14, 2026 |